Investigator Tor Biering-Sørensen summarizes the results of the DANFLU-1 trial, which tested the feasibility of using the Danish nationwide vaccine strategy and information provided solely by the Danish nationwide health registries to conduct a randomized trial comparing two doses of flu vaccine in elderly adults.
Related posts:
